Hinge Health Inc
HNGE47.920USD
-1.490-3.02%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
3.77BMarket Cap
LossP/E TTM
More Details of Hinge Health Inc Company
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
Hinge Health Inc Info
Ticker SymbolHNGE
Company nameHinge Health Inc
IPO dateMay 22, 2025
CEOPerez (Daniel Antonio)
Number of employees1514
Security typeOrdinary Share
Fiscal year-endMay 22
Address455 Market Street
CitySAN FRANCISCO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code94105
Phone14156898429
Websitehttps://en-gb.hingehealth.com/
Ticker SymbolHNGE
IPO dateMay 22, 2025
CEOPerez (Daniel Antonio)
Company Executives of Hinge Health Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Kristina M. (Kris) Leslie
Ms. Kristina M. (Kris) Leslie
Independent Director
Independent Director
36.50K
-7250.00%
Mr. Daniel (Dan) Perez
Mr. Daniel (Dan) Perez
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
--
--
Mr. Gabriel Mecklenburg
Mr. Gabriel Mecklenburg
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
--
--
Mr. James W. Budge, CPA
Mr. James W. Budge, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jim Pursley
Mr. Jim Pursley
President
President
--
--
Mr. Elliott Robinson
Mr. Elliott Robinson
Independent Director
Independent Director
--
--
Mr. Teddie Wardi
Mr. Teddie Wardi
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Kristina M. (Kris) Leslie
Ms. Kristina M. (Kris) Leslie
Independent Director
Independent Director
36.50K
-7250.00%
Mr. Daniel (Dan) Perez
Mr. Daniel (Dan) Perez
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
--
--
Mr. Gabriel Mecklenburg
Mr. Gabriel Mecklenburg
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
--
--
Mr. James W. Budge, CPA
Mr. James W. Budge, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jim Pursley
Mr. Jim Pursley
President
President
--
--
Mr. Elliott Robinson
Mr. Elliott Robinson
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q1
FY2023
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
154.21M
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 18
Updated: Thu, Dec 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Insight Venture Partners
29.09%
Coatue Management, L.L.C.
12.40%
Jane Street Capital, L.L.C.
5.62%
BIT Capital GmbH
4.88%
Pursley (James)
3.62%
Other
44.40%
Shareholders
Shareholders
Proportion
Insight Venture Partners
29.09%
Coatue Management, L.L.C.
12.40%
Jane Street Capital, L.L.C.
5.62%
BIT Capital GmbH
4.88%
Pursley (James)
3.62%
Other
44.40%
Shareholder Types
Shareholders
Proportion
Venture Capital
31.26%
Hedge Fund
29.15%
Investment Advisor
18.13%
Investment Advisor/Hedge Fund
14.10%
Research Firm
7.96%
Individual Investor
5.33%
Private Equity
3.65%
Sovereign Wealth Fund
0.79%
Pension Fund
0.19%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
237
39.98M
105.45%
+4.63M
2025Q3
168
36.74M
134.97%
+31.81M
2025Q2
33
8.44M
31.48%
+5.68M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Insight Venture Partners
11.03M
29.09%
--
--
Dec 01, 2025
Coatue Management, L.L.C.
4.70M
12.4%
--
--
Sep 30, 2025
Jane Street Capital, L.L.C.
2.13M
5.62%
+2.09M
+4618.84%
Dec 08, 2025
BIT Capital GmbH
1.85M
4.88%
+1.09M
+144.58%
Sep 30, 2025
Pursley (James)
1.37M
3.62%
-20.13K
-1.44%
Dec 22, 2025
Alyeska Investment Group, L.P.
1.29M
3.41%
-70.05K
-5.14%
Sep 30, 2025
Vitruvian Partners LLP
1.25M
3.3%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
1.23M
3.25%
+224.30K
+22.22%
Sep 30, 2025
Baron Capital Management, Inc.
944.98K
2.49%
-787.00
-0.08%
Sep 30, 2025
Braidwell LP
910.48K
2.4%
+910.48K
--
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
0.59%
Franklin Genomic Advancements ETF
0.58%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.38%
BNY Mellon US Small Cap Core Equity ETF
0.06%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity MSCI Health Care Index ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
Schwab U.S. Broad Market ETF
0%
Global X HealthTech ETF
Proportion0.59%
Franklin Genomic Advancements ETF
Proportion0.58%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.38%
BNY Mellon US Small Cap Core Equity ETF
Proportion0.06%
Schwab U.S. Small-Cap ETF
Proportion0.02%
Fidelity MSCI Health Care Index ETF
Proportion0.01%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Schwab U.S. Broad Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Hinge Health Inc?
The top five shareholders of Hinge Health Inc are:
Insight Venture Partners holds 11.03M shares, accounting for 29.09% of the total shares.
Coatue Management, L.L.C. holds 4.70M shares, accounting for 12.40% of the total shares.
Jane Street Capital, L.L.C. holds 2.13M shares, accounting for 5.62% of the total shares.
BIT Capital GmbH holds 1.85M shares, accounting for 4.88% of the total shares.
Pursley (James) holds 1.37M shares, accounting for 3.62% of the total shares.
Insight Venture Partners holds 11.03M shares, accounting for 29.09% of the total shares.
Coatue Management, L.L.C. holds 4.70M shares, accounting for 12.40% of the total shares.
Jane Street Capital, L.L.C. holds 2.13M shares, accounting for 5.62% of the total shares.
BIT Capital GmbH holds 1.85M shares, accounting for 4.88% of the total shares.
Pursley (James) holds 1.37M shares, accounting for 3.62% of the total shares.
What are the top three shareholder types of Hinge Health Inc?
The top three shareholder types of Hinge Health Inc are:
Insight Venture Partners
Coatue Management, L.L.C.
Jane Street Capital, L.L.C.
Insight Venture Partners
Coatue Management, L.L.C.
Jane Street Capital, L.L.C.
How many institutions hold shares of Hinge Health Inc (HNGE)?
As of 2025Q4, 237 institutions hold shares of Hinge Health Inc, with a combined market value of approximately 39.98M, accounting for 105.45% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -29.52%.
What is the biggest source of revenue for Hinge Health Inc?
In FY2025Q3, the -- business generated the highest revenue for Hinge Health Inc, amounting to -- and accounting for --% of total revenue.
